Menu
  • About EURO-NMD – & ERNs
    • Network Functions
      • What is EURO-NMD?
      • What are EURO-NMD Centres and how can I find one?
      • Who’s who in EURO-NMD
      • Registry Hub for Rare Neuromuscular Diseases
      • Care & Trial Site Registry
      • Clinical Patient Management System (CPMS)
      • CPMS Helpdesk
    • Events Calendar
      • ERN internal meetings
      • List of Events
      • Submit an event
      • 4th Neuromuscular Translational School
      • EURO-NMD Bursaries – 2nd round open from September 1st to November 30th, 2021
      • Newsletter
          • Our monthly newsletter

            The newsletters that we send out around the end of most months keep subscribers up to date with many different aspects of the network ranging from relevant publications to upcoming meetings and events and also general news from the wider neuromuscular community.

            • Newsletter August 2022
        • Close
      • 2020
        • January 2020
        • February 2020
        • March 2020
        • April 2020
        • May 2020
        • June 2020
        • July 2020
        • September 2020
        • October 2020
        • Close
      • 2019
        • January 2019
        • February 2019
        • March 2019
        • April 2019
        • May 2019
        • July 2019
        • Summer 2019
        • September 2019
        • October 2019
        • November 2019
        • December 2019
        • Close
      • 2018
        • January 2018
        • February 2018
        • March 2018
        • April 2018
        • May 2018
        • June 2018
        • July 2018
        • RD-Connect Webinars
        • September 2018
        • October 2018
        • December 2018
        • Close
      • 2017
        • August 2017
        • September 2017
        • October 2017
        • December 2017
        • Close
    • Close
  • Network Structure
    • Healthcare Providers
    • HCP list with CPMS code
    • Diseases Covered by EURO-NMD (Disease Groups) and cross-cutting Speciality Groups
    • Board Members
    • Executive Committee
    • Patient Advisory Board
    • Secretariat
    • Resources
    • Job Vacancies
    • Funding Opportunities
    • Close
  • Patient – engagement
    • Overview of Patient Participation in EURO-NMD – in our network
      • Improving patients’ health outcomes – The role of patient organisations
    • Patient Advisory Board
    • PAB Position Letter – Call for Proposal on Registries Dedicated to ERNs
    • New names for LGMD – Patient information leaflet
    • Close
  • Educational – resources
    • Educational Board
    • Neuromuscular Webinars
    • EURO-NMD Bursaries – 2nd round open from September 1st to November 30th, 2021
    • ERN Euro-NMD Exchange Programme 2021-2022
    • 4th Neuromuscular Translational School
      • Past Summer Schools
    • Family Care
    • Close
  • Guidelines – & protocols
    • Family care
    • Recommended Guidelines
    • Operating procedures & protocols
      • Database of shared samples
    • Close
  • Research – & clinical trials
    • How to Reference our Network in your Publications

    • Research Working Group
      The Research board comprises 100+ people who expressed some interest in research issues. Priority has been given to establishing informing research-interested HCPs about upcoming research opportunities, in particular the Solve-RD project and the European Joint Programme for RD (EJP-RD).

      • Networks of Note
        • EuroBioBank
        • RD-CONNECT
        • Solve-RD-Logo
        • TREAT-NMD Logo
      • DMD Research overview
        • The Duchenne muscular dystrophy (DMD) research overview section of the TREAT-NMD website is regularly updated by Annemieke Aartsma-Rus and provides information about the different therapuetic approaches to DMD.

          Find out more...


      • Registry Hub for Rare Neuromuscular Diseases
      • International Neuromuscular COVID-19 Database
      • Myobase – The bibliographic database of neuromuscular disorders

      • Recent publications
        • Recommendations for whole genome sequencing in diagnostics for rare diseases
        • Determination of Tafamidis Plasma Concentrations in Amyloidosis Patients with Glu89Gln Mutation by HPLC-UV Detection.
        • 239th ENMC International Workshop: Classification of dermatomyositis.
        • 252nd ENMC international workshop: Developing best practice guidelines for management of mouthpiece ventilation in neuromuscular disorders. March 6th to 8th 2020, Amsterdam, the Netherlands
        • Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies
        • Publication Search
    • COVID-19 and Neuromuscular Patients
    • Results of Survey: COVID19 Hospital Feedback
    • ENMC Themed Workshops: “Post-Covid-19: Issues and opportunities for the neuromuscular field!”
    • EURO-NMD Board & Working Groups Meeting December 2020
    • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
    • Rare disease community raises alert over discrimination in critical care guidelines during COVID-19 pandemic
    • COVID-19 and NMDs – Latest news
    • COVID19 Surveys
      • COVID-19 Patient Survey
      • COVID-19 Hospital Survey
      • COVID-19 NMD Database
    • Close
  • .
    • Close
  • .
    • Get in touch

      [iphorm id="2" name="Get in touch"]
    • Close

2017 Posters

Consortium (NeMusChALS), an integrated highly specialized and collaborative structure for clinical expertise, care and translational research for neuromuscular diseases from childhood to adulthood.


E-Health and Innovation to overcome barriers in neuromuscular diseases


European Reference Network for rare Neuromuscular Diseases: EURO-NMD


How has RD-ACTION supported the conceptualisation and implementation of European Reference Networks?


International-DMD (IDMD): a PTC Therapeutics-supported diagnostic project to identify Dystrophin mutations by NGS technologies in patients throughout European countries


Introduction of ERN NMD Centre in Prague, Czech Republic


Mitochondrial diseases : Transition from childhood into adulthood, a model of care


Molecular diagnosis of spinal muscular atrophy with lower extremity predominance by NGS analysis


Motor Neuron Diseases at the UMC of Utrecht


Neurological and Neuropathological Alterations in Nerve and Muscle Tissue in Nesprinopathies


Patient Advisory Board : The Voice of Patients with Rare Neuromuscular Diseases


Rare Commons: an innovative social media platform 2.0 for collaborative clinical research on pediatric rare diseases


Rare neuromuscular disease patient registries – key to diagnosis and novel therapies


Standardized analysis and sharing of genome-phenome data for neuromuscular and rare disease research through the RD-Connect platform


The contribution of Erasmus MC University Medical Center to the field of neuromuscular disorders.


The development of a mobile app for patients with Pompe disease and its possible clinical applications


The MYO-SEQ project: application of exome sequencing technologies to 1000 patients affected by limb-girdle weakness of unknown origin


TREAT-NMD: Advancing Diagnosis, Treatment and Care in Neuromuscular Rare Diseases


Contact us

ERN EURO-NMD coordination
Institut de Myologie
GH Pitié-Salpêtrière
47-83, Bd de l’Hôpital
75013 Paris
France

info@ern-euro-nmd.eu

 

 


Our privacy policy
Unsubscribe from our newsletter

Sign up to our Newsletter

Please complete the form below if you would like to receive our newsletter. Before you do we recommend you take a look at our privacy policy.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern“


Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}